InspireMD PE Ratio 2013-2025 | NSPR
Current and historical p/e ratio for InspireMD (NSPR) from 2013 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. InspireMD PE ratio as of February 06, 2026 is 0.00.
| InspireMD PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-02-09 | 1.77 | 0.00 | |
| 2025-09-30 | 2.41 | $-0.84 | 0.00 |
| 2025-06-30 | 2.27 | $-0.83 | 0.00 |
| 2025-03-31 | 2.69 | $-0.79 | 0.00 |
| 2024-12-31 | 2.63 | $-0.78 | 0.00 |
| 2024-09-30 | 2.68 | $-0.75 | 0.00 |
| 2024-06-30 | 2.50 | $-0.74 | 0.00 |
| 2024-03-31 | 2.37 | $-0.76 | 0.00 |
| 2023-12-31 | 2.81 | $-1.08 | 0.00 |
| 2023-09-30 | 3.27 | $-1.52 | 0.00 |
| 2023-06-30 | 2.51 | $-1.95 | 0.00 |
| 2023-03-31 | 1.13 | $-2.30 | 0.00 |
| 2022-12-31 | 0.86 | $-2.34 | 0.00 |
| 2022-09-30 | 1.48 | $-2.27 | 0.00 |
| 2022-06-30 | 2.00 | $-2.22 | 0.00 |
| 2022-03-31 | 3.20 | $-2.09 | 0.00 |
| 2021-12-31 | 3.02 | $-2.05 | 0.00 |
| 2021-09-30 | 4.10 | $-3.02 | 0.00 |
| 2021-06-30 | 5.05 | $-3.39 | 0.00 |
| 2021-03-31 | 10.05 | $-5.93 | 0.00 |
| 2020-12-31 | 5.10 | $-11.84 | 0.00 |
| 2020-09-30 | 4.80 | $-18.89 | 0.00 |
| 2020-06-30 | 7.05 | $-36.88 | 0.00 |
| 2020-03-31 | 9.30 | $-57.72 | 0.00 |
| 2019-12-31 | 16.20 | $-108.55 | 0.00 |
| 2019-09-30 | 19.50 | $-137.48 | 0.00 |
| 2019-06-30 | 51.15 | $-156.07 | 0.00 |
| 2019-03-31 | 105.00 | $-244.68 | 0.00 |
| 2018-12-31 | 120.00 | $-982.01 | 0.00 |
| 2018-09-30 | 165.00 | $-6,476.76 | 0.00 |
| 2018-06-30 | 187.50 | $-11,419.31 | 0.00 |
| 2018-03-31 | 780.00 | $-16,811.11 | 0.00 |
| 2017-12-31 | 3412.50 | $-37,247.15 | 0.00 |
| 2017-09-30 | 10500.00 | $-54,780.31 | 0.00 |
| 2017-06-30 | 17587.50 | $-72,341.46 | 0.00 |
| 2017-03-31 | 25987.50 | $-191,337.92 | 0.00 |
| 2016-12-31 | 65625.00 | $-379,792.67 | 0.00 |
| 2016-09-30 | 52500.00 | $-599,175.98 | 0.00 |
| 2016-06-30 | 210000.00 | $-891,162.90 | 0.00 |
| 2016-03-31 | 334688.00 | $-1,094,295.60 | 0.00 |
| 2015-12-31 | 577500.00 | $-1,539,877.00 | 0.00 |
| 2015-09-30 | 1000000.00 | $-2,083,748.60 | 0.00 |
| 2015-06-30 | 1000000.00 | $-3,079,754.50 | 0.00 |
| 2015-03-31 | 1000000.00 | $-4,193,708.10 | 0.00 |
| 2014-12-31 | 1000000.00 | $-4,717,921.30 | 0.00 |
| 2014-09-30 | 1000000.00 | $-3,931,601.00 | 0.00 |
| 2014-06-30 | 1000000.00 | $-3,407,387.30 | 0.00 |
| 2014-03-31 | 1000000.00 | $-5,111,080.30 | 0.00 |
| 2013-12-31 | 1000000.00 | $-5,700,821.30 | 0.00 |
| 2013-09-30 | 1000000.00 | $-5,700,821.30 | 0.00 |
| 2013-06-30 | 1000000.00 | $-7,797,675.00 | 0.00 |
| 2013-03-31 | 1000000.00 | $-4,652,395.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.074B | $0.007B |
| InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $203.946B | 23.74 |
| Intuitive Surgical (ISRG) | United States | $173.357B | 66.87 |
| IDEXX Laboratories (IDXX) | United States | $51.473B | 49.32 |
| Edwards Lifesciences (EW) | United States | $45.675B | 30.63 |
| Alcon (ALC) | Switzerland | $38.991B | 26.28 |
| IQVIA Holdings (IQV) | United States | $31.930B | 17.25 |
| Mettler-Toledo (MTD) | United States | $28.060B | 32.10 |
| DexCom (DXCM) | United States | $27.289B | 37.62 |
| STERIS (STE) | Ireland | $24.749B | 25.02 |
| Waters (WAT) | United States | $22.705B | 30.02 |
| Coloplast (CLPBY) | Denmark | $17.601B | 26.93 |
| Hologic (HOLX) | United States | $16.701B | 17.48 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.912B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.959B | 11.58 |
| Penumbra (PEN) | United States | $13.355B | 93.94 |
| Globus Medical (GMED) | United States | $11.752B | 24.67 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.474B | 23.95 |
| Glaukos (GKOS) | United States | $6.463B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.024B | 19.14 |
| Teleflex (TFX) | United States | $4.792B | 7.64 |
| TransMedics (TMDX) | United States | $4.616B | 54.68 |
| LivaNova (LIVN) | United Kingdom | $3.635B | 19.63 |
| Integer Holdings (ITGR) | United States | $3.029B | 14.22 |
| Veracyte (VCYT) | United States | $2.861B | 32.60 |
| Elekta AB (EKTAY) | Sweden | $2.241B | 20.97 |
| UFP Technologies (UFPT) | United States | $2.062B | 27.22 |
| Alphatec Holdings (ATEC) | United States | $2.053B | 0.00 |
| Artivion (AORT) | United States | $1.876B | 86.07 |
| Nihon Kohden (NHNKY) | Japan | $1.855B | 20.47 |
| AxoGen (AXGN) | United States | $1.611B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.606B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.406B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.300B | 0.00 |
| IRadimed (IRMD) | United States | $1.221B | 58.16 |
| OPKO Health (OPK) | United States | $0.952B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.877B | 4.75 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.677B | 13.51 |
| SiBone (SIBN) | United States | $0.676B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.623B | 36.25 |
| Alpha Tau Medical (DRTS) | Israel | $0.603B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.576B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.549B | 0.00 |
| NeuroPace (NPCE) | United States | $0.522B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.515B | 13.42 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.507B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.435B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.418B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.383B | 0.00 |
| RxSight (RXST) | United States | $0.345B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.331B | 55.12 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.310B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.283B | 0.00 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.226B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.177B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.168B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.160B | 0.00 |
| Inogen (INGN) | United States | $0.154B | 0.00 |
| LENSAR (LNSR) | United States | $0.144B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.118B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.118B | 0.00 |
| Hyperfine (HYPR) | United States | $0.107B | 0.00 |
| Neuronetics (STIM) | United States | $0.107B | 0.00 |
| Solana (HSDT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Accuray (ARAY) | United States | $0.070B | 0.00 |
| DarioHealth (DRIO) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.060B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.044B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.027B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.024B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Envoy Medical (COCH) | United States | $0.014B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |